(Total Views: 215)
Posted On: 02/27/2018 4:45:53 PM
Post# of 2022
NetworkNewsBreaks – EVIO, Inc. (EVIO) Releases Letter to Shareholders
EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning issued a letter to shareholders detailing its recent corporate milestones, fiscal results and projections, financing efforts and key management additions. “It is an exciting time to be involved in the cannabis industry, which is expected to double in size again by 2021 as more states look to legalize both medical and recreational cannabis use,” the letter reads. “Despite the risks inherent in any evolving marketplace, and despite the political uncertainty with respect to marijuana’s legal status on the federal level… all signs continue to point to a very bright future for one of the fastest growing industries in the nation. Moreover, cannabis testing continues to represent one of the most critical components of this industry as we move forward, however slowly, to inevitable cannabis legalization across North America. As a stable, reliable, and ever-growing market subset, mandatory testing has become the standard in the various cannabis-friendly states. Since our last shareholder update, we at EVIO have made significant progress in our mission to become synonymous with safe, high-quality cannabis for legal consumption.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning issued a letter to shareholders detailing its recent corporate milestones, fiscal results and projections, financing efforts and key management additions. “It is an exciting time to be involved in the cannabis industry, which is expected to double in size again by 2021 as more states look to legalize both medical and recreational cannabis use,” the letter reads. “Despite the risks inherent in any evolving marketplace, and despite the political uncertainty with respect to marijuana’s legal status on the federal level… all signs continue to point to a very bright future for one of the fastest growing industries in the nation. Moreover, cannabis testing continues to represent one of the most critical components of this industry as we move forward, however slowly, to inevitable cannabis legalization across North America. As a stable, reliable, and ever-growing market subset, mandatory testing has become the standard in the various cannabis-friendly states. Since our last shareholder update, we at EVIO have made significant progress in our mission to become synonymous with safe, high-quality cannabis for legal consumption.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
